Increased serum laminin and angiogenin concentrations in patients with peripheral arterial occlusive disease
- PMID: 8763269
- PMCID: PMC500545
- DOI: 10.1136/jcp.49.6.508
Increased serum laminin and angiogenin concentrations in patients with peripheral arterial occlusive disease
Abstract
Aim: To measure serum laminin and angiogenin concentrations in patients with peripheral arterial occlusive disease (PAOD) Fontaine stages IIb, III, and IV.
Methods: The study population comprised 38 patients (20 men and 18 women) with stage IV PAOD, 11 patients (six men and five women) with stage III PAOD, 18 patients (10 men and eight women) with stage IIb PAOD, and 23 patients (10 men and 13 women) with deep vein thrombosis. Fifteen normal subjects (matched for risk factors) and 10 patients (five men and five women) without PAOD served as controls. Serum samples were obtained at admission and serum laminin and angiogenin concentrations were measured using an enzyme linked immunosorbent assay.
Results: Patients with stage IV PAOD had higher serum laminin (mean +/- SEM; 826 +/- 97 ng/ml) and angiogenin concentrations (467 +/- 26 pg/ml) than normal subjects (laminin: 379 +/- 21 ng/ml; angiogenin: 358 +/- 16 pg/ml) and patients without PAOD (laminin: 277 +/- 34 ng/ml; angiogenin: 406 +/- 25 pg/ml). A significant correlation was found between angiogenin and laminin and between serum laminin and fibrinogen concentrations in patients with stage IV disease.
Conclusions: Raised laminin and angiogenin concentrations may be indicators of endothelial damage caused by reduced vascular perfusion or compensatory revascularisation, or both.
Similar articles
-
Plasma endothelin-1 levels in patients with peripheral arterial occlusive disease at different Fontaine's stages.Panminerva Med. 1999 Mar;41(1):22-6. Panminerva Med. 1999. PMID: 10230252
-
Serum hepatocyte growth factor in patients with peripheral arterial occlusive disease.J Clin Endocrinol Metab. 1999 Jul;84(7):2425-8. doi: 10.1210/jcem.84.7.5826. J Clin Endocrinol Metab. 1999. PMID: 10404815
-
Serum nitrate concentrations in patients with peripheral arterial occlusive disease.Vasa. 1999 Aug;28(3):181-4. doi: 10.1024/0301-1526.28.3.181. Vasa. 1999. PMID: 10483323
-
The prognosis of non-critical limb ischaemia: a systematic review of population-based evidence.Br J Gen Pract. 1999 Jan;49(438):49-55. Br J Gen Pract. 1999. PMID: 10622019 Free PMC article. Review.
-
Dyslipoproteinemia and peripheral arterial occlusive disease.Angiology. 2004 Mar-Apr;55(2):135-8. doi: 10.1177/000331970405500204. Angiology. 2004. PMID: 15026867 Review.
Cited by
-
Adverse effects of bone marrow stromal cell treatment of stroke in diabetic rats.Stroke. 2011 Dec;42(12):3551-8. doi: 10.1161/STROKEAHA.111.627174. Epub 2011 Sep 22. Stroke. 2011. PMID: 21940967 Free PMC article.
-
Angiogenin Levels and Carotid Intima-Media Thickness in Patients with Type 1 Diabetes and Metabolic Syndrome.Biomedicines. 2023 Sep 21;11(9):2591. doi: 10.3390/biomedicines11092591. Biomedicines. 2023. PMID: 37761032 Free PMC article.
-
Homocysteine and laminin are not prognostic markers in patients with septic inflammatory response syndrome.Clin Diagn Lab Immunol. 2000 Jan;7(1):119-21. doi: 10.1128/CDLI.7.1.119-121.2000. Clin Diagn Lab Immunol. 2000. PMID: 10618290 Free PMC article.
-
Niaspan attenuates the adverse effects of bone marrow stromal cell treatment of stroke in type one diabetic rats.PLoS One. 2013 Nov 26;8(11):e81199. doi: 10.1371/journal.pone.0081199. eCollection 2013. PLoS One. 2013. PMID: 24303036 Free PMC article.
-
Three decades of research on angiogenin: a review and perspective.Acta Biochim Biophys Sin (Shanghai). 2016 May;48(5):399-410. doi: 10.1093/abbs/gmv131. Epub 2015 Dec 23. Acta Biochim Biophys Sin (Shanghai). 2016. PMID: 26705141 Free PMC article. Review.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources